FDA drug approvals recorded by openFDA between 2026-09-20 and 2026-10-04, newest first. Company is the first listed manufacturer; tickers link to Seeking Alpha.
| Approval Date | Company | Drug | Ticker |
|---|---|---|---|
| 2026-09-30 | Creekwood Pharmaceuticals LLC | ATOMOXETINE | n/a |
| 2026-09-30 | EPIC PHARMA LLC | ACETAZOLAMIDE | n/a |
| 2026-09-30 | H2-Pharma LLC | XENICAL | n/a |
| 2026-09-30 | JAZZ | ZEPZELCA | JAZZ |
| 2026-09-30 | Myokardia, Inc. | CAMZYOS | n/a |
| 2026-09-29 | Amgen, Inc | RIABNI | AMGN |
| 2026-09-29 | Amneal Pharmaceuticals of New York LLC | LACOSAMIDE | AMNL |
| 2026-09-29 | B. Braun Medical Inc. | DEXTROSE AND SODIUM CHLORIDE | n/a |
| 2026-09-29 | CELLTRION INC | EYDENZELT | n/a |
| 2026-09-29 | CELLTRION USA, Inc. | AVTOZMA | n/a |
| 2026-09-29 | Fresenius Kabi USA, LLC | RIFAMPIN | n/a |
| 2026-09-29 | Merck Sharp & Dohme LLC | DELSTRIGO | MRK |
| 2026-09-29 | Merck Sharp & Dohme LLC | PIFELTRO | MRK |
| 2026-09-29 | XGen Pharmaceuticals DJB, Inc. | TRANEXAMIC ACID | n/a |
| 2026-09-29 | ZYDUS LIFESCIENCES | MUPIROCIN CALCIUM | n/a |
| 2026-09-28 | Accord Healthcare, Inc. | METHYLPHENIDATE HYDROCHLORIDE | n/a |
| 2026-09-28 | Agios Pharmaceuticals, Inc. | AQVESME | AGIO |
| 2026-09-28 | Amneal Pharmaceuticals LLC | LABETALOL HYDROCHLORIDE | AMNL |
| 2026-09-28 | Aurobindo Pharma Limited | MINOCYCLINE HYDROCHLORIDE | n/a |
| 2026-09-28 | GRANULES | METHYLPHENIDATE HYDROCHLORIDE | n/a |
| 2026-09-28 | Heritage Pharmaceuticals Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc. | TRANEXAMIC ACID | HRTG |
| 2026-09-28 | Kenvue Brands LLC | ZYRTEC | n/a |
| 2026-09-28 | NEPHRON | DEXMEDETOMIDINE HYDROCHLORIDE | n/a |
| 2026-09-28 | Northstar Rx LLC | METHYLPHENIDATE HYDROCHLORIDE | n/a |
| 2026-09-28 | Pfizer Laboratories Div Pfizer Inc | RUXIENCE | PFE |
| 2026-09-28 | PHARMOBEDIENT | QUINAPRIL HYDROCHLORIDE | n/a |
| 2026-09-28 | RARE THYROID THERAPEUTICS INTERNATIONAL AB | EMCITATE | n/a |
| 2026-09-28 | Sandoz Inc | BUMETANIDE | SDZWF |
| 2026-09-28 | TEVA PHARMS | DEXMETHYLPHENIDATE HYDROCHLORIDE | TEVA |
| 2026-09-28 | UPSHER SMITH LABS | PREDNISOLONE ACETATE | n/a |
| 2026-09-28 | Whole Foods Market, Inc. | 365 WHOLE FOODS MARKET POLYETHYLENE GLYCOL 3350 | n/a |
| 2026-09-25 | ADAPTIS | KETOROLAC TROMETHAMINE | n/a |
| 2026-09-25 | ADVENTAPHARMA DWC LLC | ZUEINO | n/a |
| 2026-09-25 | Alvogen Inc. | LISDEXAMFETAMINE DIMESYLATE | n/a |
| 2026-09-25 | AUROBINDO PHARMA LTD | METRONIDAZOLE | n/a |
| 2026-09-25 | Avyxa Pharma, LLC | BENDAMUSTINE HYDROCHLORIDE | n/a |
| 2026-09-25 | AZURITY PHARMACEUTICALS INC | n/a | n/a |
| 2026-09-25 | Bayer HealthCare LLC | CLARITIN | BAYRY |
| 2026-09-25 | Eli Lilly and Company | OLUMIANT | LLY |
| 2026-09-25 | Genentech, Inc. | GAZYVA | RHHBY |
| 2026-09-25 | HERITAGE PHARMS INC | DUTASTERIDE | n/a |
| 2026-09-25 | HONG KONG | THIAMINE HYDROCHLORIDE | n/a |
| 2026-09-25 | INCYTE CORP | ATEBRIOZ | INCY |
| 2026-09-25 | Northstar Rx LLC | ATOMOXETINE | n/a |
| 2026-09-25 | NOVITIUM PHARMA | ESOMEPRAZOLE MAGNESIUM | n/a |
| 2026-09-25 | PLANO PHARMS | ARGATROBAN IN SODIUM CHLORIDE | n/a |
| 2026-09-25 | PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS | ROSUVASTATIN CALCIUM | n/a |
| 2026-09-25 | RISING | CAPECITABINE | n/a |
| 2026-09-25 | SANDOZ | ROSUVASTATIN CALCIUM | SDZWF |
| 2026-09-25 | STERISCIENCE | NAFCILLIN SODIUM | n/a |
| 2026-09-25 | Strides Pharma Science Limited | ATOMOXETINE | n/a |
| 2026-09-25 | Sun Pharmaceutical Industries, Inc. | FINGOLIMOD | n/a |
| 2026-09-25 | TEVA PHARMACEUTICALS, INC. | DEGEVMA | TEVA |
| 2026-09-25 | Viona Pharmaceuticals Inc | ACYCLOVIR | n/a |
| 2026-09-25 | WATSON LABS | LOSARTAN POTASSIUM | n/a |
| 2026-09-25 | YICHANG HUMANWELL | DILTIAZEM HYDROCHLORIDE | n/a |
| 2026-09-24 | ACTAVIS LABS FL | LINACLOTIDE | n/a |
| 2026-09-24 | ANI Pharmaceuticals, Inc. | RISPERIDONE | ANIP |
| 2026-09-24 | Baxter Healthcare Corporation | DAPZURA RT | BAX |
| 2026-09-24 | Bionpharma Inc. | ATOVAQUONE | n/a |
| 2026-09-24 | Eisai Inc. | LENVIMA | n/a |
| 2026-09-24 | GRANULES | LISDEXAMFETAMINE DIMESYLATE | n/a |
| 2026-09-24 | Hospira, Inc. | BUTORPHANOL TARTRATE | n/a |
| 2026-09-24 | LANNETT CO INC | LISDEXAMFETAMINE DIMESYLATE | n/a |
| 2026-09-24 | MACLEODS PHARMS | CRISABOROLE | n/a |
| 2026-09-24 | Merck Sharp & Dohme LLC | WELIREG | MRK |
| 2026-09-24 | NEPHRON | PHENYLEPHRINE HYDROCHLORIDE | n/a |
| 2026-09-24 | Roche Laboratories Inc. | VALIUM | RHHBY |
| 2026-09-24 | TEVA PHARMS | DORZOLAMIDE HYDROCHLORIDE | TEVA |
| 2026-09-23 | AIPING PHARM INC | GLIPIZIDE | n/a |
| 2026-09-23 | ANNORA PHARMA | NORGESTIMATE AND ETHINYL ESTRADIOL | n/a |
| 2026-09-23 | APOTEX | PAXIL | n/a |
| 2026-09-23 | Apotex Corp | PAROXETINE HYDROCHLORIDE | n/a |
| 2026-09-23 | ASTRAZENECA | CRESTOR | AZN |
| 2026-09-23 | ELI LILLY AND CO | ONSWIK | LLY |
| 2026-09-23 | HORIZON THERAPEUTICS IRELAND | TEPEZZA | AMGN |
| 2026-09-23 | Mylan Pharmaceuticals Inc. | SPIRONOLACTONE | VTRS |
| 2026-09-23 | SHANDONG | KETOROLAC TROMETHAMINE | n/a |
| 2026-09-23 | STERIMAX | CLAFORAN | n/a |
| 2026-09-23 | United Therapeutics Corporation | TYVASO DPI | UTHR |
| 2026-09-23 | ZYDUS PHARMS | MEXILETINE HYDROCHLORIDE | n/a |
| 2026-09-22 | Accord Healthcare Inc. | QUETIAPINE FUMARATE | n/a |
| 2026-09-22 | Amici Pharma, Inc. | RISPERIDONE | n/a |
| 2026-09-22 | CARMEL BIOSCIENCES | PREXXARTAN | n/a |
| 2026-09-22 | GLENMARK PHARMACEUTICALS INC., USA | EPINEPHRINE | n/a |
| 2026-09-22 | INVAGEN PHARMS | EMPAGLIFLOZIN | n/a |
| 2026-09-22 | IPCA LABS LTD | AMLODIPINE BESYLATE | n/a |
| 2026-09-22 | NOVARTIS | SCEMBLIX | NVS |
| 2026-09-22 | RUBICON RESEARCH | PANTOPRAZOLE SODIUM | n/a |
| 2026-09-22 | SENORES PHARMS | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE | n/a |
| 2026-09-21 | Aurobindo Pharma Limited | VALACYCLOVIR HYDROCHLORIDE | n/a |
| 2026-09-21 | Breckenridge Pharmaceutical, Inc. | DULOXETINE DELAYED-RELEASE | n/a |
| 2026-09-21 | Dr. Reddy’s Laboratories Ltd | DIVALPROEX SODIUM | RDY |
| 2026-09-21 | LANTHEUS MEDICAL | BRAVNETSA | LNTH |
| 2026-09-21 | MACLEODS PHARMS | NEVIRAPINE | n/a |
| 2026-09-21 | Merck Sharp & Dohme LLC | WINREVAIR | MRK |
| 2026-09-21 | NOVITIUM PHARMA | EVEROLIMUS | n/a |
| 2026-09-21 | Westminster Pharmaceuticals, LLC | ACETAZOLAMIDE | n/a |
Only the 98 most relevant rows are shown. Approved applications (originals and supplements) in this window: 100; rows shown: 98; tickers identified: 31. Known pharma subsidiaries are mapped to their US-listed parent or ADR (e.g. Janssen -> JNJ, Novartis -> NVS). Companies shown as “n/a” are mostly foreign or privately held drug makers (mostly generics) with no US-listed stock.
Data source: openFDA